Search result

9 Results found

	A phase II open-label study of the safety, tolerability, pharmacokinetics and efficacy of a range of single intravenous doses of MRA in children with systemic juvenile idiopathic arthritis

	Prévention du retard de croissance par le traitement précoce par hormone de croissance recombinante humaine chez les enfants atteints de formes systémiques d'arthrite chronique juvénile et traités par corticothérapie prolongée Prevention of growth retardation with early treatment by recombinant human growth hormone in children affected with systemic forms of juvenile chronic arthritis and long-term treated with corticotherapy

	Studio di fase III, multicentrico, internazionale, randomizzato, con discontinuazione, per valutare efficacia e tolerabilità del farmaco sperimentale BMS-188667 (CTLA4IG) in bambini e adolescenti con Artrite Reumatoide Giovanile Poliarticolare (JRA) International, multicenter, randomized, phase III study on the efficacy and tolerability of the BMS-188667 (CTLA4IG) experimental drug in children and adolescents with polyarticular juvenile rheumatoid arthritis

	A pilot study of Anakinra in paediatric recurrent fevers and multisystem inflammatory diseases

	A Randomised, Double Blind Trial of Anti-TNF.Ñ Chimeric Monoclonal Antibody ( Infliximab) in combination with Methotrexate for the treatment of Patients with Polyarticular Juvenile Rheumatoid Arthritis.

	Studio clinico di fase III per stabilire i tempi sospensione del MTX (6 mesi verso 12 mesi), in pazienti con artrite idiopatica giovanile in remissione clinica Phase III study to evaluate the methotrexate suspension time (6 vs 12 months) in patients with juvenile idiopathic arthritis in remission

	STUDIO CLINICO PER STABILIRE I TEMPI DI PROSECUZIONE DEL TRATTAMENTO CON METHOTREXATE (6 MESI VERSO 12 MESI), IN PAZIENTI CON ARTRITE IDIOPATICA GIOVANILE IN REMISSIONE CLINICA

	INIBITORI DELLE PROTEASI E DI FATTORI DI TRASCRIZIONE NUCLEARE NELLE VASCULITI E NELL'ARTRITE REUMATOIDE

Results 8 of 9 found

1  2

Concept and coding by Valentina Rossi, Laboratory of Medical Informatics